bioRxiv Science⌕ Search

Biology subjects

Kelow, S.

Publications and source records attributed to Kelow, S..

4 recordsLinked to original sources

CDR Conformation Aware Antibody Sequence Design with ConformAb

Antibody lead optimization methods seek to enhance a lead candidates therapeutic properties through targeted sequence mutation. However, the mutations introduced during this process can inadvertently induce structural changes that disrupt binding, particularly by altering CDR loop conformations which destabilize CDR-target binding interactions. To address this, we present ConformAb, a guided discrete diffusion model for designing antibody sequences that explicitly conform to the CDR canonical conformation of the lead. With seed sequences as the starting point, we show that our method is capable of generating 3- 5x better binders that conform to the same CDR backbone structure in a one-shot design setup, and in some cases, binders with better affinity than seed repertoire picks without any target-specific data included in training. Across the targets tested, ConformAb demonstrated binding rates ranging from 15 -60% in wet lab experiments, a result obtained using fewer than 100 designs for each target. ConformAb offers a unique one-shot approach for antibody lead optimization in data-scarce scenarios where experimental/repertoire data cannot be leveraged for model training.

biophysics↗

Deep Evolutionary Fitness Inference for Variant Nomination from Directed Evolution

Iterative screening techniques, such as directed evolution, enable high-throughput affinity maturation to optimize binders to molecular interfaces. However, the decision problem of selecting variants from rich, evolved populations to enter low-throughput follow-up methods remains a significant bottleneck. Here, we present evolutionary fitness inference (EVFI) and DeepEVFI, two machine learning methods that model directed evolution from time-series sequencing data, and infer fitness, a variants ability to enrich under selection pressure. Our methods flexibly handle mutation mechanisms and starting populations that may be partially unknown - settings relevant to drug discovery - and achieve strong performance on a diverse set of experimental data. We conducted two experimental directed evolution campaigns, using antibodies and macrocyclic peptides libraries to identify and optimize binders to therapeutically relevant targets. EVFI and DeepEVFI identified tighter binders that were missed by human experts using conventional frequency-based approaches, including "rising stars" with low frequency. Beyond initial hit discovery, EVFI and Deep-EVFI enables labeling large-scale sequence-fitness datasets and identifying variants of initial binders with diverse properties.

bioinformatics↗

A penultimate classification of canonical antibody CDR conformations

Antibody complementarity determining regions (CDRs) are loops within antibodies responsible for engaging antigens during the immune response and in antibody therapeutics and laboratory reagents. Since the 1980s, the conformations of the hypervariable CDRs have been structurally classified into a number of "canonical conformations" by Chothia, Lesk, Thornton, and others. In 2011 (North et al, J Mol Biol. 2011), we produced a quantitative clustering of approximately 300 structures of each CDR based on their length, a dihedral angle metric, and an affinity propagation algorithm. The data have been made available on our PyIgClassify website since 2015 and have been widely used in assigning conformational labels to antibodies in new structures and in molecular dynamics simulations. In the years since, it is has become apparent that many of the clusters are not "canonical" since they have not grown in size and still contain few sequences. Some clusters represent multiple conformations, given the assignment method we have used since 2015. Electron density calculations indicate that some clusters are due to misfitting of coordinates to electron density. In this work, we have performed a new statistical clustering of antibody CDR conformations. We used Electron Density in Atoms (EDIA, Meyder et al., 2017) to produce data sets with different levels of electron density validation. Clusters were chosen by their presence in high electron density cutoff data sets and with sufficient sequences ([≥]10) across the entire PDB (no EDIA cutoff). About half of the North et al. clusters have been "retired" and 13 new clusters have been identified. We also include clustering of the H4 and L4 CDRs, otherwise known as the "DE loop" which connects strands D and E of the variable domain. The DE loop sometimes contacts antigens and affects the structure of neighboring CDR1 and CDR2 loops. The current database contains 6,486 PDB antibody entries. The new clustering will be useful in the analysis and development of new antibody structure prediction and design algorithms based on rapidly emerging techniques in deep learning. The new clustering data are available at http://dunbrack2.fccc.edu/PyIgClassify2.

immunology↗

Function-guided protein design by deep manifold sampling

Protein design is challenging because it requires searching through a vast combinatorial space that is only sparsely functional. Self-supervised learning approaches offer the potential to navigate through this space more effectively and thereby accelerate protein engineering. We introduce a sequence denoising autoencoder (DAE) that learns the manifold of protein sequences from a large amount of potentially unlabelled proteins. This DAE is combined with a function predictor that guides sampling towards sequences with higher levels of desired functions. We train the sequence DAE on more than 20M unlabeled protein sequences spanning many evolutionarily diverse protein families and train the function predictor on approximately 0.5M sequences with known function labels. At test time, we sample from the model by iteratively denoising a sequence while exploiting the gradients from the function predictor. We present a few preliminary case studies of protein design that demonstrate the effectiveness of this proposed approach, which we refer to as "deep manifold sampling", including metal binding site addition, function-preserving diversification, and global fold change.

bioinformatics↗